Bessemer Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARQT
Bessemer Group's ARQT Position: Q3 2026 in Review
Bessemer Group held its Arcutis Biotherapeutics (ARQT) position steady in Q3 2026 at 190 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #2270.
Bessemer Group first reported a position in ARQT in Q2 2024 and has held it in 7 quarters since. 294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.
- Bessemer Group held 190 shares of Arcutis Biotherapeutics worth $5K as of Q3 2026.
- Bessemer Group left its Arcutis Biotherapeutics share count unchanged in Q3 2026.
- Arcutis Biotherapeutics made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #2270 holding.
- Bessemer Group first reported a position in Arcutis Biotherapeutics in Q2 2024 and has held it in 7 quarters since.
- 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.
Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.